{
    "id": 29366,
    "fullName": "EML4 - NTRK3",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EML4-NTRK3 results from the fusion of EML4 and NTRK3 and leads to transformation of cultured cells and activation of MAPK signaling in a reporter assay (PMID: 30279230). EML4-NTRK3 has been identified in MSI-high colorectal cancer (PMID: 30279230).",
            "references": [
                {
                    "id": 13140,
                    "pubMedId": 30279230,
                    "title": "Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30279230"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 27436,
        "geneSymbol": "EML4",
        "terms": [
            "EML4",
            "C2orf2",
            "ELP120",
            "EMAP-4",
            "EMAPL4",
            "ROPP120"
        ]
    },
    "variant": "EML4 - NTRK3",
    "createDate": "02/18/2019",
    "updateDate": "02/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 4916,
                "geneSymbol": "NTRK3",
                "terms": [
                    "NTRK3",
                    "gp145(trkC)",
                    "GP145-TrkC",
                    "TRKC"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 16051,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rozlytrek (entrectinib) inhibited growth of transformed cells expressing EML4-NTRK3 in culture (PMID: 30279230).",
            "molecularProfile": {
                "id": 31385,
                "profileName": "EML4 - NTRK3"
            },
            "therapy": {
                "id": 1455,
                "therapyName": "Entrectinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 13140,
                    "pubMedId": 30279230,
                    "title": "Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30279230"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31385,
            "profileName": "EML4 - NTRK3",
            "profileTreatmentApproaches": [
                {
                    "id": 19352,
                    "name": "Larotrectinib",
                    "profileName": "EML4 - NTRK3"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}